← All stocks

Propanc Biopharma, Inc.

PPCB No buying or selling
CIK 0001517681 #5559 in the set updated 21 Sep 2026
Bought (120 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

2 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Nathanielsz James Andrew
CEO/CFO
8,728,004
+218,200,000%
Kenyon Julian Norman
Chief Scientific Officer
3,420,005
+68,400,000%

No percentages here. This company's share count has moved by a factor of 44,758.1 over the window, from 15,372 to 688,022,017 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 7
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 12,148,000
History held since 27 Sep 2016